These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 26303764)

  • 1. Response to Letter to the Editor: Effects of New Antiplatelet Agents and Aldosterone Receptor Antagonists on Mortality in Patients with Myocardial Infarction.
    Abualsuod A
    Cardiovasc Drugs Ther; 2015 Oct; 29(5):497. PubMed ID: 26303764
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of New Antiplatelet Agents and Aldosterone Receptor Antagonists on Mortality in Patients with Myocardial Infarction.
    Eyuboglu M
    Cardiovasc Drugs Ther; 2015 Oct; 29(5):495. PubMed ID: 26233242
    [No Abstract]   [Full Text] [Related]  

  • 3. The Effect of Metformin Use on Left Ventricular Ejection Fraction and Mortality Post-Myocardial Infarction.
    Abualsuod A; Rutland JJ; Watts TE; Pandat S; Delongchamp R; Mehta JL
    Cardiovasc Drugs Ther; 2015 Jun; 29(3):265-75. PubMed ID: 26068409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Metformin and left ventricular remodeling after acute myocardial infarction: molecular mechanisms and clinical implications].
    Paneni F; Costantino S; Cosentino F
    G Ital Cardiol (Rome); 2015 Apr; 16(4):225-31. PubMed ID: 25959758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Metformin on Metabolites and Relation With Myocardial Infarct Size and Left Ventricular Ejection Fraction After Myocardial Infarction.
    Eppinga RN; Kofink D; Dullaart RP; Dalmeijer GW; Lipsic E; van Veldhuisen DJ; van der Horst IC; Asselbergs FW; van der Harst P
    Circ Cardiovasc Genet; 2017 Feb; 10(1):. PubMed ID: 28100626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of ramipril and spironolactone on ventricular remodeling after acute myocardial infarction: randomized and double-blind study].
    Rodríguez JA; Godoy I; Castro P; Quintana JC; Chávez E; Yovanovich J; Corbalán R; Chávez A
    Rev Med Chil; 1997 Jun; 125(6):643-52. PubMed ID: 9515282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study answers long-standing question about metformin after heart attack.
    Caffrey MK
    Am J Manag Care; 2014 May; 20(8 Spec No.):E14. PubMed ID: 25617933
    [No Abstract]   [Full Text] [Related]  

  • 8. Acute coronary syndromes: Metformin not associated with improved left ventricular function after STEMI in patients without diabetes mellitus.
    Mearns BM
    Nat Rev Cardiol; 2014 Jun; 11(6):314. PubMed ID: 24736756
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effects of nifedipine on global and regional function of the left ventricle in patients with acute myocardial infarction].
    Wang J
    Zhonghua Xin Xue Guan Bing Za Zhi; 1990 Apr; 18(2):101-3. PubMed ID: 2209400
    [No Abstract]   [Full Text] [Related]  

  • 10. The beneficial effect of insulin, glucose, and dipyridamole on regional left ventricular function early after acute myocardial infarction.
    Bedetti G; Pizzi C; Gabrieli L; Varga A; Pasanisi E; Bugiardini R; Picano E
    Int J Cardiol; 2005 Jul; 102(2):255-8. PubMed ID: 15982493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of liraglutide on left ventricular function in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Chen WR; Hu SY; Chen YD; Zhang Y; Qian G; Wang J; Yang JJ; Wang ZF; Tian F; Ning QX
    Am Heart J; 2015 Nov; 170(5):845-54. PubMed ID: 26542491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, double-blind, placebo-controlled study of the safety and efficacy of intravenous MCC-135 as an adjunct to primary percutaneous coronary intervention in patients with acute myocardial infarction: Evaluation of MCC-135 for left ventricular salvage in acute myocardial infarction (EVOLVE).
    Jang IK; Weissman NJ; Picard MH; Zile MR; Pettigrew V; Shen S; Tatsuno J; Hibberd MG; Tzivoni D; Wackers FJ;
    Am Heart J; 2008 Jan; 155(1):113.e1-8. PubMed ID: 18082500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardioprotective effects of exenatide in patients with ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention: results of exenatide myocardial protection in revascularization study.
    Woo JS; Kim W; Ha SJ; Kim JB; Kim SJ; Kim WS; Seon HJ; Kim KS
    Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2252-60. PubMed ID: 23868944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin is associated with improved left ventricular diastolic function measured by tissue Doppler imaging in patients with diabetes.
    Andersson C; Søgaard P; Hoffmann S; Hansen PR; Vaag A; Major-Pedersen A; Hansen TF; Bech J; Køber L; Torp-Pedersen C; Gislason GH
    Eur J Endocrinol; 2010 Oct; 163(4):593-9. PubMed ID: 20679358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin improves cardiac function in mice with heart failure after myocardial infarction by regulating mitochondrial energy metabolism.
    Sun D; Yang F
    Biochem Biophys Res Commun; 2017 Apr; 486(2):329-335. PubMed ID: 28302481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Effect of Metformin on Diastolic Function in Patients Presenting with ST-Elevation Myocardial Infarction.
    Al Ali L; Hartman MT; Lexis CP; Hummel YM; Lipsic E; van Melle JP; van Veldhuisen DJ; Voors AA; van der Horst IC; van der Harst P
    PLoS One; 2016; 11(12):e0168340. PubMed ID: 27977774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delayed Results of Experimental Afobazole Therapy in Rats after Acute Myocardial Infarction.
    Kryzhanovskii SA; Tsorin IB; Stolyaruk VN; Ionova EO; Vititnova MB
    Bull Exp Biol Med; 2017 Jun; 163(2):180-183. PubMed ID: 28726201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin prevents myocardial reperfusion injury by activating the adenosine receptor.
    Paiva M; Riksen NP; Davidson SM; Hausenloy DJ; Monteiro P; Gonçalves L; Providência L; Rongen GA; Smits P; Mocanu MM; Yellon DM
    J Cardiovasc Pharmacol; 2009 May; 53(5):373-8. PubMed ID: 19295441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myocardial infarct size reduction with pexelizumab: the role of chance is patently clear.
    Gibson CM; Pride YB
    JACC Cardiovasc Imaging; 2010 Jan; 3(1):61-3. PubMed ID: 20129532
    [No Abstract]   [Full Text] [Related]  

  • 20. [THE EFFECT OF CYTOFLAVIN ON PARAMETERS OF THE LEFT VENTRICULAR SYSTOLIC FUNCTION IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION.].
    Pereverzev DI; Simonova NV; Dorovskikh VA; Anokhina RA
    Eksp Klin Farmakol; 2017; 80(1):14-17. PubMed ID: 29873997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.